ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
-0.50%
US Tech 100
18,385.60
0.37%
S&P 500
5,306.04
0.02%
US Dollar vs CAD
1.36461
0.12%
Bitcoin
68,513.43
-1.27%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vaxxinity Inc (VAXX)

  7. Vaxxinity Inc (VAXX) News

VAXX

Vaxxinity (VAXX)

Vaxxinity Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VAXX
DateTimeSourceHeadlineSymbolCompany
05/09/20243:24PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:VAXXVaxxinity Inc
05/09/20243:09PMEdgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:VAXXVaxxinity Inc
04/19/20245:53PMGlobeNewswire Inc.Vaxxinity Issues Shareholder LetterNASDAQ:VAXXVaxxinity Inc
04/19/20243:27PMGlobeNewswire Inc.Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common StockNASDAQ:VAXXVaxxinity Inc
03/28/20248:23AMGlobeNewswire Inc.Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual MeetingNASDAQ:VAXXVaxxinity Inc
03/27/20243:41PMGlobeNewswire Inc.Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:VAXXVaxxinity Inc
03/07/20249:32AMGlobeNewswire Inc.Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024NASDAQ:VAXXVaxxinity Inc
02/15/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VAXXVaxxinity Inc
02/15/20247:00AMGlobeNewswire Inc.Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data PublishedNASDAQ:VAXXVaxxinity Inc
02/13/20247:00AMGlobeNewswire Inc.Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024NASDAQ:VAXXVaxxinity Inc
02/12/20244:02PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VAXXVaxxinity Inc
02/12/20244:02PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VAXXVaxxinity Inc
01/30/20247:00AMGlobeNewswire Inc.Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of FloridaNASDAQ:VAXXVaxxinity Inc
01/18/20247:00AMGlobeNewswire Inc.Vaxxinity Announces Collaboration on Space Medicine Research with University of Central FloridaNASDAQ:VAXXVaxxinity Inc
01/03/20247:00AMGlobeNewswire Inc.Vaxxinity to Present at the 2024 J.P. Morgan Healthcare ConferenceNASDAQ:VAXXVaxxinity Inc
12/01/20239:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VAXXVaxxinity Inc
11/30/20234:03PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
11/30/20233:54PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
11/29/20234:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
11/29/20234:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
11/21/20233:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
11/21/20233:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
11/13/20235:50PMGlobeNewswire Inc.Vaxxinity to Present at Upcoming November Medical and Investor ConferencesNASDAQ:VAXXVaxxinity Inc
11/08/20237:30AMGlobeNewswire Inc.Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:VAXXVaxxinity Inc
11/08/20236:53AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VAXXVaxxinity Inc
11/03/20233:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VAXXVaxxinity Inc
10/04/20233:33PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
10/04/20233:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
09/28/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VAXXVaxxinity Inc
09/22/20233:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
 Showing the most relevant articles for your search:NASDAQ:VAXX

Your Recent History

USOTC
ACRL
Atacama Resources (PK)
USOTC
EPAZ
Epazz (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
MWWC
Marketing Worldwide (PK)
USOTC
SAPX
Seven Arts Entertainment (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
FCEL
FuelCell Energy
NASDAQ
TSLA
Tesla
USOTC
HHSE
Hannover House (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved